Literature DB >> 14981672

A new measure of prognostic separation in survival data.

Patrick Royston1, Willi Sauerbrei.   

Abstract

Multivariable prognostic models are widely used in cancer and other disease areas, and have a range of applications in clinical medicine, clinical trials and allocation of health services resources. A well-founded and reliable measure of the prognostic ability of a model would be valuable to help define the separation between patients or prognostic groups that the model could provide, and to act as a benchmark of model performance in a validation setting. We propose such a measure for models of survival data. Its motivation derives originally from the idea of separation between Kaplan-Meier curves. We define the criteria for a successful measure and discuss them with respect to our approach. Adjustments for 'optimism', the tendency for a model to predict better on the data on which it was derived than on new data, are suggested. We study the properties of the measure by simulation and by example in three substantial data sets. We believe that our new measure will prove useful as a tool to evaluate the separation available-with a prognostic model. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 14981672     DOI: 10.1002/sim.1621

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  156 in total

1.  Quantifying predictive accuracy in survival models.

Authors:  Seth T Lirette; Inmaculada Aban
Journal:  J Nucl Cardiol       Date:  2015-10-19       Impact factor: 5.952

2.  Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of QCancer(®) (Pancreas).

Authors:  Gary S Collins; Douglas G Altman
Journal:  Br J Gen Pract       Date:  2013-09       Impact factor: 5.386

3.  High-sensitive factor I and C-reactive protein based biomarkers for coronary artery disease.

Authors:  Qing Zhao; Jian-Shi Du; Dong-Mei Han; Ying Ma
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.

Authors:  Daniel Mankarios; Peter Baade; Pip Youl; Robin H Mortimer; Adedayo A Onitilo; Anthony Russell; Suhail A R Doi
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

5.  survcomp: an R/Bioconductor package for performance assessment and comparison of survival models.

Authors:  Markus S Schröder; Aedín C Culhane; John Quackenbush; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2011-09-07       Impact factor: 6.937

6.  A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes.

Authors:  Thomas Pa Debray; Johanna Aag Damen; Richard D Riley; Kym Snell; Johannes B Reitsma; Lotty Hooft; Gary S Collins; Karel Gm Moons
Journal:  Stat Methods Med Res       Date:  2018-07-23       Impact factor: 3.021

7.  The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.

Authors:  Maryam Dosani; Scott Tyldesley; Brendan Bakos; Jeremy Hamm; Tim Kong; Sarah Lucas; Jordan Wong; Mitchell Liu; Sarah Hamilton
Journal:  Support Care Cancer       Date:  2018-02-01       Impact factor: 3.603

8.  Incident heart failure prediction in the elderly: the health ABC heart failure score.

Authors:  Javed Butler; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Rhonda Belue; Nicolas Rodondi; Melissa Garcia; Douglas C Bauer; Suzanne Satterfield; Andrew L Smith; Viola Vaccarino; Anne B Newman; Tamara B Harris; Peter W F Wilson; Stephen B Kritchevsky
Journal:  Circ Heart Fail       Date:  2008-07       Impact factor: 8.790

9.  Prediction Accuracy Measures for a Nonlinear Model and for Right-Censored Time-to-Event Data.

Authors:  Gang Li; Xiaoyan Wang
Journal:  J Am Stat Assoc       Date:  2019-03-11       Impact factor: 5.033

10.  An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.

Authors:  Gary S Collins; Douglas G Altman
Journal:  BMJ       Date:  2009-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.